Malaria: Offering Children a Chance
For the first time, MSF is employing seasonal malaria chemoprevention (SMC) in Chad and Mali. 170,000 children aged between three months and five years received anti-malaria medicines during the peak transmission season. This treatment, recommended by the World Health Organization, will not eradicate malaria definitively. But in countries like Chad and Mali, where malaria is the first cause of infant and child mortality, it does have an important role to play in emergency situations.